PROCÉDÉS SYNTHÉTIQUES AMÉLIORÉS DE PRODUCTION DE COMPOSÉS HÉTÉROCYCLIQUES FUSIONNÉS UTILISÉS EN TANT QUE MODULATEURS DU RÉCEPTEUR DE L'OREXINE

Processes for preparing (((3aR,6aS)-5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanoneare described, which are useful for commercial manufacturing. Said compound is an orexin receptor modulator and may be useful in pharmaceutical...

Full description

Saved in:
Bibliographic Details
Main Authors GALA, Dinesh, DEPRÉ, Dominique Paul Michel, HUYGAERTS, Andy Josephina Joannes, MATCHA, Kiran, MOENS, Luc Jozef Raphael
Format Patent
LanguageFrench
Published 23.02.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract Processes for preparing (((3aR,6aS)-5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanoneare described, which are useful for commercial manufacturing. Said compound is an orexin receptor modulator and may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia and depression.
AbstractList Processes for preparing (((3aR,6aS)-5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanoneare described, which are useful for commercial manufacturing. Said compound is an orexin receptor modulator and may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia and depression.
Author HUYGAERTS, Andy Josephina Joannes
MATCHA, Kiran
GALA, Dinesh
MOENS, Luc Jozef Raphael
DEPRÉ, Dominique Paul Michel
Author_xml – fullname: GALA, Dinesh
– fullname: DEPRÉ, Dominique Paul Michel
– fullname: HUYGAERTS, Andy Josephina Joannes
– fullname: MATCHA, Kiran
– fullname: MOENS, Luc Jozef Raphael
BookMark eNqFjUsKwjAURTPQgb8lCJk5EkTtAkL6SgP51CYBOypF4kjaQt1EluB6sjETde7ocbnnnrdEs37o3QK9qlrR4PPgNdaNNGXwhl0saExE8JypOjU54MjllhqmZEpUiUrpVKVB8FHSUP4dFlZHSqbSGsbZBwOJDZEGRwKLaOLEgK2j2eL4gUKVYjLznarhyiSs0fzePSa3-d0V2hZgaLl349C6aexurnfPVpDsfMwO5PSvfwOa40w4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID MA54250A
GroupedDBID EVB
ID FETCH-epo_espacenet_MA54250A3
IEDL.DBID EVB
IngestDate Fri Oct 11 05:27:45 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MA54250A3
Notes Application Number: MA20190054250
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220223&DB=EPODOC&CC=MA&NR=54250A
ParticipantIDs epo_espacenet_MA54250A
PublicationCentury 2000
PublicationDate 20220223
PublicationDateYYYYMMDD 2022-02-23
PublicationDate_xml – month: 02
  year: 2022
  text: 20220223
  day: 23
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Janssen Pharmaceutica N.V
RelatedCompanies_xml – name: Janssen Pharmaceutica N.V
Score 3.3787076
Snippet Processes for preparing (((3aR,6aS)-5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanoneare...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title PROCÉDÉS SYNTHÉTIQUES AMÉLIORÉS DE PRODUCTION DE COMPOSÉS HÉTÉROCYCLIQUES FUSIONNÉS UTILISÉS EN TANT QUE MODULATEURS DU RÉCEPTEUR DE L'OREXINE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220223&DB=EPODOC&locale=&CC=MA&NR=54250A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NToNAEN5oNepNq41_NXsw9URsCxQ5EEOXbYrhT1hMe2oEIfHSNi3GZ-ARfB5ezNkt_hw04cDuzH6EgW92gJkFoWvofumpeSZBaJBLSjaQpeRZ06W7XO-mPT3TMpHy73qDcaw8TNRJnW3Ba2HEOqHvYnFEYFQKfC-Ev17-vMSyRG7l-jZ5ha7F_YgZVqd-Ou7zTe5YQ4MGvuWTDiEGuC4vNFS4N7vmNtqBEFrjTKBPQ16Rsvw9nYwO0W4ASPPiCG3lqybaJ19_XWuiPbf-2A27Ne_Wx-gjCH1SlVZVRjiaemxclcx-jGmETbcqHdsPucSiGPSsWOSF8Bbx3cCPuIgPqEoAmRJnM3AUczfqcWHMbMcWatTDzPQYBg3sApJjMhqHgBxjOAKhAW9yZOfGD-nE9ugJao8oI2MJznH2bcyZa25MIbdQY76YZ6cI9xU157GTNkiA0lqS9LtZT1d0JdUgeFTTM9T6G-P8P8EFOuBXQpR-y5eoUazesjZM3kVyJSz_CYFynQI
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1PT4MwFG90GudNp4v_phzMPBG3AWMcFsNKF1AoyIrZTosgJF62ZZvxM_AR_Dx8MV87_HPQpAfa9_ojtH2vr-W9FqFrKH5pa1kqg2mQyWraVeT4WTfkXma0kraR6qlw-fdo147U-7E2Lr0teCyMOCf0XRyOCBKVgLyvhb5e_GxiWcK3cnUbv0LR_G7I-lazXB13eFKa1qBPAt_ycRPjPqguGvY1GJstcxvtgHnd4zcdkKcBj0hZ_J5OhgdoNwCk2foQbWXLGqrir1vXamjPK392w2Mpd6sj9BGEPi5yq8hH0mhCmV3kzHmMyEgyvSJ3HT_kFItIwGdFwi-E57DvBf6Ik3iFIgeQCXY3FYcRV6OUEyPmuI5gI1RiJmUScEgeILkmI1EIyJEEb8Ak4FmO7N74IRk7lByjxpAwbMvwjdPvxpx65qYplDqqzOaz9ARJHVXLuO2kd2MQaT2OO620baiGmuhgPGrJKar_jXH2H-EKVW3muVPXoQ_naJ_3iggDVy5QZb18Sxswka_jS9ELnwhYn_I
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PROC%C3%89D%C3%89S+SYNTH%C3%89TIQUES+AM%C3%89LIOR%C3%89S+DE+PRODUCTION+DE+COMPOS%C3%89S+H%C3%89T%C3%89ROCYCLIQUES+FUSIONN%C3%89S+UTILIS%C3%89S+EN+TANT+QUE+MODULATEURS+DU+R%C3%89CEPTEUR+DE+L%27OREXINE&rft.inventor=GALA%2C+Dinesh&rft.inventor=DEPR%C3%89%2C+Dominique+Paul+Michel&rft.inventor=HUYGAERTS%2C+Andy+Josephina+Joannes&rft.inventor=MATCHA%2C+Kiran&rft.inventor=MOENS%2C+Luc+Jozef+Raphael&rft.date=2022-02-23&rft.externalDBID=A&rft.externalDocID=MA54250A